大博医疗收盘上涨2.43%，滚动市盈率69.47倍，总市值139.73亿元

Group 1 - The core viewpoint of the article highlights that Dabo Medical's stock closed at 33.75 yuan, with a 2.43% increase, and a rolling PE ratio of 69.47 times, resulting in a total market capitalization of 13.973 billion yuan [1] - Dabo Medical ranks 103rd in the medical device industry, which has an average PE ratio of 46.15 times and a median of 29.13 times [1] - As of the Q3 2024 report, 142 institutions hold shares in Dabo Medical, with a total of 13.8455 million shares valued at 427 million yuan [1] Group 2 - Dabo Medical's main business involves the production, research, and sales of high-value medical consumables, including orthopedic trauma implants, spinal implants, joint implants, sports medicine and neurosurgery implants, minimally invasive surgical consumables, and dental implants [1] - The latest performance report for Q3 2024 shows that the company achieved an operating income of 1.529 billion yuan, a year-on-year increase of 35.88%, and a net profit of 240 million yuan, a year-on-year increase of 145.48%, with a gross profit margin of 68.47% [1]